Open AccessHodgkin’s lymphoma associated with hemophagocytic lymphohistiocytosis: A challenging combination
Author(s) -
Arif Alam,
Fatima AlKendi,
Jihad Kanbar,
Mohammed Jaloudi
Publication year - 2016
Publication title -
advances in modern oncology research
Language(s) - English
Resource type - Journals
eISSN - 2424-7855
pISSN - 2424-7847
DOI - 10.18282/amor.v2.i3.65
Subject(s) - procarbazine , hemophagocytic lymphohistiocytosis , medicine , bleomycin , etoposide , vincristine , hodgkin lymphoma , prednisone , lymphoma , cyclophosphamide , dacarbazine , oncology , cancer research , chemotherapy , disease
Hemophagocytic lymphohistiocytosis (HLH) is a hyper inflammatory disorder. In this case report, we described our experience with an associated diagnosis of Hodgkin’s lymphoma (HL) and a therapeutic course using “bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone” (BEACOPP) chemotherapy to treat both HLH and HL.